From the Journals
Latest News
Global youth depression and anxiety doubled during pandemic
Meta-analysis indicates that more mental health resources must be allocated to cope with the aftermath of COVID-19.
From the Journals
‘Munchausen by Internet’ crises a warning for all HCPs
“The ease of carrying out Munchausen behaviors makes me think that it must be much more common than it ever was,” said Dr. Marc Feldman.
From the Journals
Androgenetic alopecia fuels negative emotions and poor quality of life
Poor quality of life, but not depression, was significantly impacted by androgenetic alopecia in a meta-analysis.
From the Journals
FDA’s fast-track approval process exposed as lax, in need of reform
Once drugs are approved through this pathway, they are rarely taken off the market, a new study finds.
From the Journals
Prevalence of dementia before age 65 much higher than expected
These new prevalence data imply that there are approximately 175,000 persons with young-onset dementia in the United States.
From the Journals
Study highlights impact of acne in adult women on quality of life, mental health
The researchers observed that most participants did not think oral antibiotics were appropriate treatments for their acne, specifically because of...
From the Journals
Coffee and the brain: ‘Concerning’ new data
High levels of consumption may have adverse long-term effects on the brain.
From the Journals
PUFAs a promising add-on for borderline personality disorder
Adjunctive omega-3 fatty polyunsaturated fatty acids significantly reduce overall BPD symptom severity, a meta-analysis of four RTCs shows.
From the Journals
More on GRADE: Cognitive deficits linked to CV risk factors in T2D
Hyperlipidemia and hypertension predict modest cognitive impairment even in diabetes of limited duration, but one expert urges caution: “The...
From the Journals
Ketamine and psychosis risk: New data
“Our findings could encourage clinicians and researchers to examine a broadened indication for ketamine treatment,” said Dr. Jolien K.E. Veraart...
From the Journals
Strong support for causal role of cannabis in schizophrenia
"Our study clearly indicates that cannabis should not be considered harmless," wrote Dr. Carsten Hjorthøj.